TWO ABSTRACTS AT AACR CONFERENCE PRESENT DETAILED STUDY DESI

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a late stage, oncology-focused drug development company, is pleased to announce two...

Related Keywords

Australia , United States , Sydney , New South Wales , France , American , Michael Esquerre , Joel Tuyaret , Michael Fitzgerald , Marie Mandron Evotec , Philippe Cassier , Maha Ayyoub , Philippe Rochaix , Lise Davenne , Pierre Benoit Ancey , Clara Maria Scarlata , Nathalie Delesque Touchard , Marie Mandron , Carlos Gomez Roca , Christophe Caux , Pierre Fons , Jean Pierre Delord , Gaelle Badet , Pierre Fons Evotec , Myriam Estrabaut , James Garner , Adamc Smith , Celine Poussereau Pomie , Amy Klawitter , Kazia Therapeutics Limited , Prnewswire Kazia Therapeutics Limited , Genentech , Kazia Therapeutics , Therapeutics Limited , Annual Meeting , American Association , Cancer Research , New Orleans , Gomez Roca , Leesa Gentry , Orphan Drug Designation , Fast Track Designation , Rare Pediatric Disease Designation , Orphan Designation , Chief Executive Officer ,